You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 10,195,273


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,195,273
Title:Selectively altering microbiota for immune modulation
Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.
Inventor(s): Clube; Jasper (London, GB)
Assignee: SNIPR TECHNOLOGIES LIMITED (London, GB)
Application Number:15/820,296
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of U.S. Patent 10,195,273: A Detailed Analysis

Introduction

Patent 10,195,273, like any other patent, is a complex document that outlines the scope, claims, and innovations of a specific invention. To analyze this patent, it is crucial to delve into the various components that define its validity, applicability, and impact within the patent landscape.

Patent Overview

Patent Number and Title

U.S. Patent 10,195,273 is a utility patent that has been granted by the United States Patent and Trademark Office (USPTO). The title of the patent provides the first clue about the nature of the invention.

Inventors and Assignees

The inventors and assignees listed on the patent are critical as they indicate the individuals or organizations responsible for the invention and those who hold the rights to it.

Filing and Grant Dates

The filing date and grant date are essential for understanding the timeline of the patent application process and when the patent became enforceable.

Claims Analysis

Independent and Dependent Claims

Patent claims are the heart of any patent, defining the scope of protection. Independent claims stand alone and define the invention, while dependent claims build upon the independent claims, adding additional limitations[3].

Claim Language and Scope

The language used in the claims is crucial. It must be clear, concise, and specific enough to define the invention without being overly broad. The scope of the claims determines what is protected and what is not. For example, the USPTO's guidance on AI patents emphasizes that claims must integrate judicial exceptions into practical applications to be patent-eligible[1].

Examples from Recent Guidance

The 2024 USPTO guidance update on AI patents provides valuable insights into how claims should be drafted. For instance, Example 48 illustrates how specifying the use of separated audio components in a real-time speech recognition system can transform an abstract idea into a patent-eligible invention by providing a practical application[1].

Patent Scope and Breadth

Metrics for Measuring Patent Scope

Research has shown that metrics such as independent claim length and independent claim count can be used to measure patent scope. These metrics have explanatory power for correlates of patent scope, such as patent maintenance payments, forward citations, and the breadth of patent classes[3].

Impact on Patent Quality

The breadth of a patent can impact its quality. Narrower claims are often associated with a higher probability of grant and a shorter examination process, while broader claims may face more scrutiny and potential rejections[3].

Technological Classification

International Patent Classification (IPC)

Patents are classified under the World Intellectual Property Organization (WIPO) classification system, which includes 35 International Patent Classification (IPC) technical fields. This classification helps in understanding the technological area in which the patent falls and its relevance to broader trends in innovation[4].

Trends in Patent Grants

The USPTO data shows that certain technological fields, such as electrical and mechanical engineering, dominate the patent landscape. For instance, electrical engineering patents more than doubled between 2000 and 2018, driven in part by advancements in information and communication technologies (ICT)[4].

Enablement and Written Description

Guidelines for Assessing Enablement

The USPTO's guidelines for assessing enablement in utility applications emphasize the need for the patent specification to provide sufficient information to enable a person of ordinary skill in the art to make and use the invention. This is particularly important in light of recent Supreme Court decisions[5].

Written Description Requirement

The written description requirement ensures that the patent specification adequately describes the invention. This is crucial for ensuring that the claims are supported by the disclosure and that the invention is fully described.

Real-World Applications and Practical Benefits

Case Studies and Examples

To bolster the argument for patent eligibility, it is essential to highlight the real-world applications and practical benefits of the invention. For example, in the context of AI patents, demonstrating how an abstract idea is applied in a way that provides concrete benefits or solves specific problems is crucial[1].

Industry Impact

Understanding the industry impact of the patent involves analyzing how it fits into existing technological trends and how it might influence future innovations. This includes considering the potential for licensing, litigation, and collaboration.

Legal and Policy Considerations

Recent Case Law and Guidance

The integration of recent case law and guidance, such as the 2024 USPTO update on AI patents, is essential for ensuring consistency and clarity in the application of patent eligibility criteria. This helps in reflecting the latest judicial thinking and ensuring that patents are granted in a manner that aligns with current legal standards[1].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes are resolved, especially for smaller inventors and businesses. This includes considerations of legal, policy, and practical implications[2].

Key Takeaways

  • Claims Drafting: The language and scope of claims are critical for defining the invention and ensuring patent eligibility.
  • Practical Applications: Demonstrating real-world applications and practical benefits is essential for transforming abstract ideas into patent-eligible inventions.
  • Technological Classification: Understanding the technological classification helps in placing the patent within broader trends in innovation.
  • Enablement and Written Description: Ensuring that the patent specification meets the enablement and written description requirements is vital for the validity of the patent.
  • Legal and Policy Considerations: Staying updated with recent case law and guidance is crucial for navigating the patent landscape effectively.

FAQs

What is the significance of the 2024 USPTO guidance update on AI patents?

The 2024 USPTO guidance update on AI patents refines and clarifies the process for determining the patent eligibility of AI-related inventions, providing examples and integrating recent case law to ensure consistency and clarity.

How do metrics like independent claim length and count impact patent scope?

Metrics such as independent claim length and count can measure patent scope and have explanatory power for correlates of patent scope, such as patent maintenance payments and forward citations.

What is the role of the International Patent Classification (IPC) system?

The IPC system classifies patents into 35 technical fields, helping to understand the technological area of the patent and its relevance to broader trends in innovation.

Why is the enablement requirement important in patent applications?

The enablement requirement ensures that the patent specification provides sufficient information for a person of ordinary skill in the art to make and use the invention, which is crucial for the validity of the patent.

What are the potential benefits of a small claims patent court?

A small claims patent court could provide a more accessible and cost-effective way for smaller inventors and businesses to resolve patent disputes, addressing legal, policy, and practical considerations.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent Small Claims Court - ACUS
  3. Patent Claims and Patent Scope - SSRN
  4. Invention: U.S. and Comparative Global Trends - NCSES
  5. Guidelines for Assessing Enablement in Utility Applications and ... - Federal Register

More… ↓

⤷  Subscribe

Details for Patent 10,195,273

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Llc KEYTRUDA pembrolizumab For Injection 125514 September 04, 2014 10,195,273 2036-06-05
Merck Sharp & Dohme Llc KEYTRUDA pembrolizumab Injection 125514 January 15, 2015 10,195,273 2036-06-05
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 December 22, 2014 10,195,273 2036-06-05
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 October 04, 2017 10,195,273 2036-06-05
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 August 27, 2021 10,195,273 2036-06-05
Genentech, Inc. TECENTRIQ atezolizumab Injection 761034 May 18, 2016 10,195,273 2036-06-05
Genentech, Inc. TECENTRIQ atezolizumab Injection 761034 March 08, 2019 10,195,273 2036-06-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.